Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer-Reference-Cited by-同舟云学术

Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer

Published:2010-10-12 Issue:1 Volume:11 Page:
ISSN:1471-2172
Container-title:BMC Immunology
language:en
Short-container-title:BMC Immunol

Author:

Hu Zhiwei,Li Jing

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1186/1471-2172-11-49.pdf

Reference57 articles.

1. Alessi P, Ebbinghaus C, Neri D: Molecular targeting of angiogenesis. Biochim Biophys Acta. 2004, 1654: 39-49.

2. Folkman J: Angiogenesis inhibitors: a new class of drugs. Cancer Biol Ther. 2003, 2: S127-33.

3. Patterson DM, Rustin GJ: Vascular damaging agents. Clin Oncol (R Coll Radiol). 2007, 19: 443-56.

4. Pilat MJ, Lorusso PM: Vascular disrupting agents. J Cell Biochem. 2006, 99: 1021-39. 10.1002/jcb.20783.

5. Siemann DW, Bibby MC, Dark GG, Dicker AP, Eskens FA, Horsman MR, Marme D, Lorusso PM: Differentiation and definition of vascular-targeted therapies. Clin Cancer Res. 2005, 11: 416-20.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK cell based immunotherapy against oral squamous cell carcinoma;Frontiers in Immunology;2024-08-13

2. Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review;Frontiers in Immunology;2024-04-17

3. Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer;Biomarker Research;2023-06-06

4. Medical Treatments of Endometriosis: A Review;Reproductive and Developmental Medicine;2022-11-09

5. Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy;International Immunopharmacology;2022-08